H3K27me3 polyclonal antibody - Premium

Name	H3K27me3 polyclonal antibody - Premium
Supplier	Diagenode
Catalog	C15410195
Prices	$375.00
Sizes	50 μg/27 μl
Host	Rabbit
Clonality	Polyclonal
Applications	ChIPseq ChIP-PCR WB ELISA DB ICC/IF Array
Species Reactivities	Human, Mouse
Purity/Format	Affinity purified
Description	Rabbit Polyclonal
Supplier Page	Shop

Product images

<strong>Figure 1. ChIP results obtained with the Diagenode antibody directed against H3K27me3</strong><br /> ChIP assays were performed using human K562 cells, the Diagenode antibody against H3K27me3 (cat. No. pAb-195-050) and optimized PCR primer pairs for qPCR. ChIP was performed with the “iDeal ChIP-seq” kit (cat. No. AB-001-0024), using sheared chromatin from 100,000 cells. A titration consisting of 0.1, 0.5, and 1 μg of antibody per ChIP experiment was analyzed. IgG (1 μg/IP) was used as a negative IP control. Quantitative PCR was performed with primers specific for the promoter of the active genes GAPDH and EIF4A2, used as negative controls, and TSH2B and MYT1, used as positive controls. The figure shows the recovery, expressed as a % of input (the relative amount of immunoprecipitated DNA compared to input DNA after qPCR analysis).

Figure 1. ChIP results obtained with the Diagenode antibody directed against H3K27me3
ChIP assays were performed using human K562 cells, the Diagenode antibody against H3K27me3 (cat. No. pAb-195-050) and optimized PCR primer pairs for qPCR. ChIP was performed with the “iDeal ChIP-seq” kit (cat. No. AB-001-0024), using sheared chromatin from 100,000 cells. A titration consisting of 0.1, 0.5, and 1 μg of antibody per ChIP experiment was analyzed. IgG (1 μg/IP) was used as a negative IP control. Quantitative PCR was performed with primers specific for the promoter of the active genes GAPDH and EIF4A2, used as negative controls, and TSH2B and MYT1, used as positive controls. The figure shows the recovery, expressed as a % of input (the relative amount of immunoprecipitated DNA compared to input DNA after qPCR analysis).

<strong>Figure 2. ChIP-seq results obtained with the Diagenode antibody directed against H3K27me3</strong><br /> ChIP was performed on sheared chromatin from 100,000 K562 cells using 1 μg of the Diagenode antibody against H3K27me3 (cat. No. pAb-195-050) as described above. The IP’d DNA was subsequently analysed on an Illumina Genome Analyzer. Library preparation, cluster generation and sequencing were performed according to the manufacturer’s instructions. The 36 bp tags were aligned to the human genome using the ELAND algorithm. Figure 2A and B show the signal distribution in two regions surrounding the MYT1 and TSH2B positive control genes, respectively. The position of the PCR amplicon, used for ChIP-qPCR is indicated with an arrow. Figure 2C shows the signal distribution in a 5 Mb region from chromosome 22.

Figure 2. ChIP-seq results obtained with the Diagenode antibody directed against H3K27me3
ChIP was performed on sheared chromatin from 100,000 K562 cells using 1 μg of the Diagenode antibody against H3K27me3 (cat. No. pAb-195-050) as described above. The IP’d DNA was subsequently analysed on an Illumina Genome Analyzer. Library preparation, cluster generation and sequencing were performed according to the manufacturer’s instructions. The 36 bp tags were aligned to the human genome using the ELAND algorithm. Figure 2A and B show the signal distribution in two regions surrounding the MYT1 and TSH2B positive control genes, respectively. The position of the PCR amplicon, used for ChIP-qPCR is indicated with an arrow. Figure 2C shows the signal distribution in a 5 Mb region from chromosome 22.

<strong>Figure 3. Determination of the antibody titer</strong><br />To determine the titer of the antibody, an ELISA was performed using a serial dilution of the Diagenode antibody against H3K27me3 (cat. No. pAb-195-050). The antigen used was a peptide containing the histone modification of interest. By plotting the absorbance against the antibody dilution (Figure 3), the titer of the antibody was estimated to be 1:22,400.

Figure 3. Determination of the antibody titer
To determine the titer of the antibody, an ELISA was performed using a serial dilution of the Diagenode antibody against H3K27me3 (cat. No. pAb-195-050). The antigen used was a peptide containing the histone modification of interest. By plotting the absorbance against the antibody dilution (Figure 3), the titer of the antibody was estimated to be 1:22,400.

<strong>Figure 4. Cross reactivity tests using the Diagenode antibody directed against H3K27me3</strong><br /> Figure 4A. To test the cross reactivity of the Diagenode antibody against H3K27me3 (cat. No. pAb-195-050), a Dot Blot analysis was performed with peptides containing other modifications or unmodified sequences of histone H3 and H4. One hundred to 0.2 pmol of the respective peptides were spotted on a membrane. The antibody was used at a dilution of 1:20,000. Figure 4A shows a high specificity of the antibody for the modification of interest. Figure 4B. The specificity of the antibody was further demonstrated by peptide array analyses on an array containing 384 peptides with different combinations of modifications from histone H3, H4, H2A and H2B. The antibody was used at a dilution of 1:20,000. Figure 4B shows the specificity factor, calculated as the ratio of the average intensity of all spots containing the mark, divided by the average intensity of all spots not containing t

Figure 4. Cross reactivity tests using the Diagenode antibody directed against H3K27me3
Figure 4A. To test the cross reactivity of the Diagenode antibody against H3K27me3 (cat. No. pAb-195-050), a Dot Blot analysis was performed with peptides containing other modifications or unmodified sequences of histone H3 and H4. One hundred to 0.2 pmol of the respective peptides were spotted on a membrane. The antibody was used at a dilution of 1:20,000. Figure 4A shows a high specificity of the antibody for the modification of interest. Figure 4B. The specificity of the antibody was further demonstrated by peptide array analyses on an array containing 384 peptides with different combinations of modifications from histone H3, H4, H2A and H2B. The antibody was used at a dilution of 1:20,000. Figure 4B shows the specificity factor, calculated as the ratio of the average intensity of all spots containing the mark, divided by the average intensity of all spots not containing t

<strong>Figure 5. Western blot analysis using the Diagenode antibody directed against H3K27me3</strong><br /> Western blot was performed on whole cell (25 μg, lane 1) and histone extracts (15 μg, lane 2) from HeLa cells, and on 1 μg of recombinant histone H2A, H2B, H3 and H4 (lane 3, 4, 5 and 6, respectively) using the Diagenode antibody against H3K27me3 (cat. No. pAb-195-050). The antibody was diluted 1:1,000 in TBS-Tween containing 5% skimmed milk. The position of the protein of interest is shown on the right, the marker (in kDa) is shown on the left.

Figure 5. Western blot analysis using the Diagenode antibody directed against H3K27me3
Western blot was performed on whole cell (25 μg, lane 1) and histone extracts (15 μg, lane 2) from HeLa cells, and on 1 μg of recombinant histone H2A, H2B, H3 and H4 (lane 3, 4, 5 and 6, respectively) using the Diagenode antibody against H3K27me3 (cat. No. pAb-195-050). The antibody was diluted 1:1,000 in TBS-Tween containing 5% skimmed milk. The position of the protein of interest is shown on the right, the marker (in kDa) is shown on the left.

<strong>Figure 6. Immunofluorescence using the Diagenode antibody directed against H3K27me3</strong><br /> Mouse NIH3T3 cells were stained with the Diagenode antibody against H3K27me3 (cat. No. pAb-195-050) and with DAPI. Cells were fixed with 4% formaldehyde for 10’ and blocked with PBS/TX-100 containing 5% normal goat serum and 1% BSA. The cells were immunofluorescently labeled with the H3K27me3 antibody (top) diluted 1:500 in blocking solution followed by an anti-rabbit antibody conjugated to Alexa488. The middle panel shows staining of the nuclei with DAPI. A merge of the two stainings is shown at the bottom.

Figure 6. Immunofluorescence using the Diagenode antibody directed against H3K27me3
Mouse NIH3T3 cells were stained with the Diagenode antibody against H3K27me3 (cat. No. pAb-195-050) and with DAPI. Cells were fixed with 4% formaldehyde for 10’ and blocked with PBS/TX-100 containing 5% normal goat serum and 1% BSA. The cells were immunofluorescently labeled with the H3K27me3 antibody (top) diluted 1:500 in blocking solution followed by an anti-rabbit antibody conjugated to Alexa488. The middle panel shows staining of the nuclei with DAPI. A merge of the two stainings is shown at the bottom.